In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database

[1]  Ming Sun,et al.  Diversity and dynamics of bacteriocins from human microbiome. , 2015, Environmental microbiology.

[2]  Zhinan Xu,et al.  Identification and Characterization of a New Erythromycin Biosynthetic Gene Cluster in Actinopolyspora erythraea YIM90600, a Novel Erythronolide-Producing Halophilic Actinomycete Isolated from Salt Field , 2014, PloS one.

[3]  Rashidul Haque,et al.  Members of the human gut microbiota involved in recovery from Vibrio cholerae infection , 2014, Nature.

[4]  Peter Cimermancic,et al.  A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics , 2014, Cell.

[5]  S. Prakash,et al.  Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats , 2014, BioMed research international.

[6]  D. Sareen,et al.  Novel LanT Associated Lantibiotic Clusters Identified by Genome Database Mining , 2014, PloS one.

[7]  J. Vederas,et al.  Purification and characterization of antimicrobial peptides from fish isolate Carnobacterium maltaromaticum C2: Carnobacteriocin X and carnolysins A1 and A2. , 2014, International journal of food microbiology.

[8]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[9]  P. G. Arnison,et al.  Erratum: Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature (Natural Product Reports (2013) 30 (108-160) DOI:10.1039/C2NP20085F) , 2013 .

[10]  Liping Zhao,et al.  A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome , 2013, FEMS microbiology ecology.

[11]  H. Flint,et al.  A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance. , 2013, Anaerobe.

[12]  Jens Nielsen,et al.  Assessing the Human Gut Microbiota in Metabolic Diseases , 2013, Diabetes.

[13]  Jan Verhaegen,et al.  A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis , 2013, Gut.

[14]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[15]  Eduardo Marcos Balciunas,et al.  Bacteriocin production by Bifidobacterium spp. A review. , 2013, Biotechnology advances.

[16]  Oscar P. Kuipers,et al.  BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides , 2013, Nucleic Acids Res..

[17]  C. Hill,et al.  Isolation and characterization of bacteriocin‐producing bacteria from the intestinal microbiota of elderly Irish subjects , 2013, Journal of applied microbiology.

[18]  R. P. Ross,et al.  Bacteriocins — a viable alternative to antibiotics? , 2012, Nature Reviews Microbiology.

[19]  H. Flint,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[20]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[21]  D. O'sullivan,et al.  Contribution of the Actinobacteria to the growing diversity of lantibiotics , 2012, Biotechnology Letters.

[22]  Y. Sanz,et al.  Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity , 2012, PloS one.

[23]  Neha Garg,et al.  Lantibiotics from Geobacillus thermodenitrificans , 2012, Proceedings of the National Academy of Sciences.

[24]  J. Clemente,et al.  The Impact of the Gut Microbiota on Human Health: An Integrative View , 2012, Cell.

[25]  M. Claesson,et al.  Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota , 2012, PloS one.

[26]  H. Flint,et al.  Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon , 2012, The ISME Journal.

[27]  E. Murphy,et al.  Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity , 2012, Gut.

[28]  J. Hsu,et al.  Production and Characterization of a Bacteriocin from Ruminal Bacterium Ruminococcus albus 7 , 2012, Bioscience, biotechnology, and biochemistry.

[29]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[30]  R. P. Ross,et al.  Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters , 2011, PloS one.

[31]  D. Haft,et al.  Biological Systems Discovery In Silico: Radical S-Adenosylmethionine Protein Families and Their Target Peptides for Posttranslational Modification , 2011, Journal of bacteriology.

[32]  W. A. van der Donk,et al.  Genome mining for ribosomally synthesized natural products. , 2011, Current opinion in chemical biology.

[33]  M. Hattori,et al.  Bifidobacteria can protect from enteropathogenic infection through production of acetate , 2011, Nature.

[34]  K. Entian,et al.  Entianin, a Novel Subtilin-Like Lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with High Antimicrobial Activity , 2011, Applied and Environmental Microbiology.

[35]  Micheal C. Wilson,et al.  The Discovery of Salinosporamide K from the Marine Bacterium “Salinispora pacifica” by Genome Mining Gives Insight into Pathway Evolution , 2011, Chembiochem : a European journal of chemical biology.

[36]  R. P. Ross,et al.  In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria , 2010, BMC Genomics.

[37]  Y. Sanz,et al.  Intestinal Bacteroides species associated with coeliac disease , 2010, Journal of Clinical Pathology.

[38]  Douglas A. Mitchell,et al.  Plantazolicin, a Novel Microcin B17/Streptolysin S-Like Natural Product from Bacillus amyloliquefaciens FZB42 , 2010, Journal of bacteriology.

[39]  J. Tap,et al.  Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.

[40]  C. Hill,et al.  Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon , 2010, Proceedings of the National Academy of Sciences.

[41]  K. Imaizumi,et al.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial , 2010, European Journal of Clinical Nutrition.

[42]  J. Vederas,et al.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile , 2010, Proceedings of the National Academy of Sciences.

[43]  Y. Sanz,et al.  Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women , 2010, British Journal of Nutrition.

[44]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[45]  M. Bibb,et al.  Discovery of Unique Lanthionine Synthetases Reveals New Mechanistic and Evolutionary Insights , 2010, PLoS biology.

[46]  Saraswathi Abhiman,et al.  Amidoligases with ATP-grasp, glutamine synthetase-like and acetyltransferase-like domains: synthesis of novel metabolites and peptide modifications of proteins. , 2009, Molecular bioSystems.

[47]  A. Martí,et al.  Interplay Between Weight Loss and Gut Microbiota Composition in Overweight Adolescents , 2009, Obesity.

[48]  A. Martí,et al.  Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents , 2009, International Journal of Obesity.

[49]  Paul D. Cotter,et al.  Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM Proteins , 2009, Applied and Environmental Microbiology.

[50]  Wei Chen,et al.  Antimicrobial activity and partial characterization of bacteriocin-like inhibitory substances (BLIS) produced by Bifidobacterium infantis BCRC 14602 , 2009 .

[51]  R. P. Ross,et al.  Discovery of medically significant lantibiotics. , 2009, Current drug discovery technologies.

[52]  C. Hill,et al.  Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract. , 2009, FEMS microbiology letters.

[53]  J. Chapman,et al.  The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome , 2008, Proceedings of the National Academy of Sciences.

[54]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[55]  Hannah M. Wexler,et al.  Bacteroides: the Good, the Bad, and the Nitty-Gritty , 2007, Clinical Microbiology Reviews.

[56]  C. Hill,et al.  Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 , 2007, Proceedings of the National Academy of Sciences.

[57]  R. P. Ross,et al.  Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. , 2007, FEMS microbiology letters.

[58]  Neil L. Kelleher,et al.  Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic , 2006, Proceedings of the National Academy of Sciences.

[59]  C. Hill,et al.  Bacteriocins: Biological tools for bio-preservation and shelf-life extension , 2006 .

[60]  M. Sakamoto,et al.  Bacteroides dorei sp. nov., isolated from human faeces. , 2006, International journal of systematic and evolutionary microbiology.

[61]  C. Hill,et al.  Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. P. Ross,et al.  Food microbiology: Bacteriocins: developing innate immunity for food , 2005, Nature Reviews Microbiology.

[63]  Matthew Berriman,et al.  ACT: the Artemis comparison tool , 2005, Bioinform..

[64]  P. Weimer,et al.  Albusin B, a Bacteriocin from the Ruminal Bacterium Ruminococcus albus 7 That Inhibits Growth of Ruminococcus flavefaciens , 2004, Applied and Environmental Microbiology.

[65]  M. Fons,et al.  Ruminococcin A, a New Lantibiotic Produced by aRuminococcus gnavus Strain Isolated from Human Feces , 2001, Applied and Environmental Microbiology.

[66]  Kim Rutherford,et al.  Artemis: sequence visualization and annotation , 2000, Bioinform..

[67]  L. Lobo,et al.  Production of bacteriocin by Bacteroides fragilis and partial characterization , 1999 .

[68]  D. Diep,et al.  A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export , 1995, Molecular microbiology.

[69]  L. Vuyst,et al.  Bacteriocins of Lactic Acid Bacteria , 1994 .

[70]  F. Robb,et al.  Characterization and mode of action of a bacteriocin produced by a Bacteroides fragilis strain , 1979, Antimicrobial Agents and Chemotherapy.

[71]  J. Johnson,et al.  Bacteriocin Production by Strains of Bacteroides Isolated from Human Feces and the Role of These Strains in the Bacterial Ecology of the Colon , 1977, Antimicrobial Agents and Chemotherapy.

[72]  G. Reuter.  Designation of Type Strains for Bifidobacterium Species , 1971 .

[73]  Orin C. Shanks,et al.  Human fecal source identification with real-time quantitative PCR. , 2014, Methods in molecular biology.

[74]  M. R. Fernandes,et al.  Intestinal Bacteroides and Parabacteroides species producing antagonistic substances , 2013 .

[75]  P. G. Arnison,et al.  Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. , 2013, Natural product reports.

[76]  W. Verstraete,et al.  Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. , 2012, The Journal of nutritional biochemistry.

[77]  D. Sinderen,et al.  Bifidobacteria : genomics and molecular aspects , 2010 .

[78]  M. Riley,et al.  Molecular mechanisms of bacteriocin evolution. , 1998, Annual review of genetics.